Ebrahimi S - Search Results

1

Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome.

Ebrahimi S, Teimoori A, Khanbabaei H, Tabasi M. Ebrahimi S, et al. Rev Med Virol. 2019 Jan;29(1):e2009. doi: 10.1002/rmv.2009. Epub 2018 Sep 27. Rev Med Virol. 2019. PMID: 30260068 Review.

2

Analysis of NSP4 Gene and Its Association with Genotyping of Rotavirus Group A in Stool Samples.

Teimoori A, Nejati M, Ebrahimi S, Makvandi M, Zandi M, Azaran A. Teimoori A, et al. Among authors: ebrahimi s. Iran Biomed J. 2018 Jan 1;22(1):42-9. doi: 10.22034/ibj.22.1.42. Epub 2017 Jul 11. Iran Biomed J. 2018. PMID: 28693095 Free PMC article.

3

Distribution of Rotavirus Genotypes Ccirculating in Ahvaz, Iran in 2016.

Azaran A, Makvandi M, Teimoori A, Ebrahimi S, Heydari F, Nikfar R. Azaran A, et al. Among authors: ebrahimi s. Iran Biomed J. 2018 Mar;22(2):107-16. doi: 10.22034/ibj.22.2.107. Epub 2017 Sep 16. Iran Biomed J. 2018. PMID: 28915725 Free PMC article.

4

Zinc Sulfate in Narrow Range as an In Vitro Anti-HSV-1 Assay.

Fani M, Khodadad N, Ebrahimi S, Nahidsamiei R, Makvandi M, Teimoori A, Langari H. Fani M, et al. Among authors: ebrahimi s. Biol Trace Elem Res. 2020 Feb;193(2):410-413. doi: 10.1007/s12011-019-01728-0. Epub 2019 Apr 26. Biol Trace Elem Res. 2020. PMID: 31028520 Free PMC article.

5

Prevalence and genetic diversity of HCV among HIV-1 infected individuals living in Ahvaz, Iran.

Teimoori A, Ebrahimi S, Keshtkar N, Khaghani S, Salmanzadeh S, Ghafari S. Teimoori A, et al. Among authors: ebrahimi s. BMC Infect Dis. 2019 May 8;19(1):389. doi: 10.1186/s12879-019-4052-x. BMC Infect Dis. 2019. PMID: 31068133 Free PMC article.

6

In vitro effect of some nucleoside reverse transcriptase inhibitors against HSV-1 replication.

Nahid Samiei R, Ebrahimi S, Fani M, Ghafari S, Makvandi M, Khodadad N, Tabasi M, Teimoori A. Nahid Samiei R, et al. Among authors: ebrahimi s. Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1454-1459. doi: 10.26355/eurrev_202002_20204. Eur Rev Med Pharmacol Sci. 2020. PMID: 32096195 Free article.

7

Developing oncolytic Herpes simplex virus type 1 through UL39 knockout by CRISPR-Cas9.

Ebrahimi S, Makvandi M, Abbasi S, Azadmanesh K, Teimoori A. Ebrahimi S, et al. Iran J Basic Med Sci. 2020 Jul;23(7):937-944. doi: 10.22038/ijbms.2020.43864.10286. Iran J Basic Med Sci. 2020. PMID: 32774817 Free PMC article.

8

CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19.

Ebrahimi S, Khanbabaei H, Abbasi S, Fani M, Soltani S, Zandi M, Najafimemar Z. Ebrahimi S, et al. Avicenna J Med Biotechnol. 2022 Jan-Mar;14(1):3-9. doi: 10.18502/ajmb.v14i1.8165. Avicenna J Med Biotechnol. 2022. PMID: 35509363 Free PMC article. Review.

9

Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.

Khanbabaei H, Ebrahimi S, García-Rodríguez JL, Ghasemi Z, Pourghadamyari H, Mohammadi M, Kristensen LS. Khanbabaei H, et al. Among authors: ebrahimi s. J Exp Clin Cancer Res. 2022 Sep 16;41(1):278. doi: 10.1186/s13046-022-02488-x. J Exp Clin Cancer Res. 2022. PMID: 36114510 Free PMC article. Review.

10

In vitro evaluation of CRISPR PX-LmGP63 vector effect on pathogenicity of Leishmania major as a primary step to control leishmaniasis.

Ebrahimi S, Kalantari M, Alipour H, Azizi K, Asgari Q, Bahreini MS. Ebrahimi S, et al. Microb Pathog. 2021 Dec;161(Pt A):105281. doi: 10.1016/j.micpath.2021.105281. Epub 2021 Nov 6. Microb Pathog. 2021. PMID: 34752910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page